Always up to date.

News Release

29.01.2026

Merz Therapeutics Launches ‘Celebrating the Fighters’...

Merz Therapeutics North America today announced the launch of ‘Celebrating the Fighters,’ a nationwide campaign that honors the fighting spirit of...

News Release

16.10.2025

Merz Therapeutics Partners with The University of Alabama...

RALEIGH, N.C. – October 16, 2025 – Merz Therapeutics’ U.S. subsidiary announced today the opening of the Merz Therapeutics Training Room at the...

News Release

30.07.2024

Merz Therapeutics Appoints Leonard Paolillo as President of...

Merz Therapeutics announces today the appointment of Leonard Paolillo as President, Merz Therapeutics North America, effective immediately. In this...

News Release

10.07.2024

Merz Therapeutics Closes $185M Asset Purchase Agreement...

Acquisition of INBRIJA (levodopa inhalation powder) and (F)AMPYRA (fampridine) expands specialty neurology portfolio. Lays groundwork for Parkinson’s...

News Release

13.12.2023

Merz Therapeutics North America Earns Great Place To Work...

Merz Therapeutics announced today that is has earned the Great Place to Work^® CertificationTM for both its United States (U.S.) and...

News Release

27.07.2022

Merz Therapeutics to present robust data on...

Merz Therapeutics announced today the presentation of data from 10 accepted abstracts on XEOMIN^® (incobotulinumtoxinA) at TOXINS 2022:...

Press Contact

Nicole Lovern
Corporate Communications
Merz Therapeutics
6601 Six Forks Road, Suite 400, Raleigh, NC 27615
(571) 442-9665
Nicole.Lovern@merz.com

Platform change – You are leaving this page.

You are leaving this website. With respect to the content of the following page, as well as to links to other websites located on this page, Merz Therapeutics U.S. has no way of controlling the content of these sites. Merz Therapeutics U.S. assumes no responsibility for the content of these sites or the consequences of their use by visitors. However, we ask you to notify us immediately of any illegal content on the linked sites.

Change of country – You are leaving this page.

You are leaving this website. The content of the following sites maintained by the parent company or another affiliated company, or links to other sites located on this site, is subject to the legal requirements of the country in which the site is maintained. Merz Therapeutics U.S. accepts no responsibility whatsoever for the content of these websites or for the consequences of their use by visitors. However, we ask you to notify us immediately of any illegal content on the linked sites.